Yeah a nice end to March quarter. With the 5 MTAs (?) in the last 12 months and other possible deals it is not out of the question for a significant payment to be received before the end of the year. I thought I read that the Genentech deal was an extension of exclusivity of 6 months (?) so small possibility that there is still a milestone this year from them too.
If the data pack is as good as people are hoping then the likelihood of some sort of transaction around the end of 2017 (+/- 3 months) is high and if any of the recent comparisons doing the rounds are even a guide then it could be double or triple digit millions. On the other hand they might raise some cash along the way to increase the probability by concurrently developing YB1 & Stat5 - either way I'll be happy but I'd still like a CEO before a year is up . . . .
PYC Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)